Lymphatic Vessel Neoplasm — knowledge graph · CancerIndex

Knowledge graph · Cancer

Lymphatic Vessel Neoplasm

subtype

Identifier: CI-CAN-00001099
Entity page: /cancer/lymphatic-vessel-neoplasm ↗
Edges: 16

Neighbours: 4 drugs10 trials
Drawn: 14 of 14 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Lymphatic Vessel Neoplasm investigated in trials for …INVESTIGATED_IN_TRIALSderived4 of 4
→ investigated in trials for	Alpelisibsmall molecule 2 trials (1 active) · roll-up of the cancer and its descendants	—	—	Lymphatic Vessel Neoplasm	2	Observed	clinicaltrials	graph →
→ investigated in trials for	Sirolimussmall molecule 2 trials (0 active) · roll-up of the cancer and its descendants

Lymphatic Vessel Neoplasm studied in …STUDIED_INderived10 of 12show all (up to 200)
→ studied in	NCT05983159Phase 2 · recruiting A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations · condition mapped ONTOLOGY_EXACT · 12 trials mapped (4 active)	—	—	Lymphangioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06239480Phase 3 · active not recruiting SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations · condition mapped ALIAS · 12 trials mapped (4 active)	—	—	Lymphangioma Circumscriptum	1	Observed	clinicaltrials	graph →
→ studied in	NCT07477548Phase 2 · not yet recruiting A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies · condition mapped ONTOLOGY_EXACT · 12 trials mapped (4 active)	—	—	Lymphangioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT00975819Phase 2 · completed Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies · condition mapped ALIAS · 12 trials mapped (4 active)	—	—	Lymphangioma Circumscriptum	1	Observed	clinicaltrials	graph →
→ studied in	NCT06943703completed Bleomycin as an Effective and Curative Adjunct Therapy for Lymphangioma · condition mapped ONTOLOGY_EXACT · 12 trials mapped (4 active)	—	—	Lymphangioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06892964NA · recruiting Institution of an Italian Registry and Biobank for Biological Sample Collection · condition mapped ONTOLOGY_EXACT · 12 trials mapped (4 active)	—	—	Lymphangioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT05050149Phase 2 · completed Study Evaluating the Safety and Efficacy of PTX-022 (QTORIN Sirolimus) in the Treatment of Microcystic Lymphatic Malformations · condition mapped ALIAS · 12 trials mapped (4 active)	—	—	Lymphangioma Circumscriptum	1	Observed	clinicaltrials	graph →
→ studied in	NCT06257719completed Clinical Characteristics of Lymphatic Malformations · condition mapped ONTOLOGY_EXACT · 12 trials mapped (4 active)	—	—	Lymphangioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT03941782no longer available Compassionate Use of BYL 719 Alpelisib · condition mapped ONTOLOGY_EXACT · 12 trials mapped (4 active)	—	—	Lymphangioma	1	Observed	clinicaltrials	graph →
→ studied in	NCT06160739unknown Role of Sirolimus in Treatment of Microcystic , Mixed Lymphatic and Vascular Malformations · condition mapped ALIAS · 12 trials mapped (4 active)	—	—	Lymphangioma Circumscriptum	1	Observed	clinicaltrials	graph →